and will diagnose diseases without requiring specialized laboratories particularly useful in regions with limited access to doctors and hospitals.
and allows it to time-release. y allowing rapid detection of disease and preventing agricultural chemical release into the environment,
Samples taken from a single individual could be analyzed this way, opening applications for disease diagnostics and research.
or not could be used to better understand the progression of disease. any researchers, Saven said,
ave observed these long tangles of aggregated peptides and proteins in diseases like Alzheimer and Parkinson,
and investigate the staging of a disease. An international team of researchers, led by Dr Munitta Muthana from the University of Sheffield's Department of Oncology,
which exploit modified human cells to treat diseases such as cancer, have advanced greatly over recent years.
According to UC Davis researchers, these sponge-like nanoporous gold hold the potential for enabling new devices to detect agents responsible for causing disease in both plants
It almost like a natural sieve. arly identification of disease biomarkers and pathogenic microbes is possible with the swift and sensitive detection of nucleic acids.
Going forward, the team anticipates that their research will be useful in the progress of mini point-of-care diagnostic systems for clinical and agricultural applications. he applications of the sensor are quite broad ranging from detection of plant pathogens to disease biomarkers,
For instance, in human sepsis cases, the illness can be detected early on, thereby preventing any needless treatments as doctors can now establish bacterial contamination much more rapidly than ever before.
According to UC Davis researchers, these sponge-like nanoporous gold hold the potential for enabling new devices to detect agents responsible for causing disease in both plants
Early identification of disease biomarkers and pathogenic microbes is possible with the swift and sensitive detection of nucleic acids.
Going forward, the team anticipates that their research will be useful in the progress of mini point-of-care diagnostic systems for clinical and agricultural applications. he applications of the sensor are quite broad ranging from detection of plant pathogens to disease biomarkers
For instance, in human sepsis cases, the illness can be detected early on, thereby preventing any needless treatments as doctors can now establish bacterial contamination much more rapidly than ever before.
#Microfluidics Technology-Based Lab-on-a-chip Device Could Reduce Cost of Sophisticated Tests for Diseases Rutgers engineers have developed a breakthrough device that can significantly reduce the cost of sophisticated lab tests for medical disorders
and diseases, such as HIV, Lyme disease and syphilis. The new device uses miniaturized channels and valves to replace"benchtop"assays-tests that require large samples of blood
The discovery could also lead to more comprehensive research on autoimmune joint diseases such as rheumatoid arthritis through animal studies.
which metastasizes at an early disease stage making treatment extremely difficult, Zharov said. His team will use new high-pulse-rate lasers,
especially in early disease stages, the researchers proposed genetic, laser and nanotechnological methods to increase diagnostic and therapeutic efficiency.
Zharov said. t will help to better distinguish melanoma-associated small changes in photoacoustic signals at early disease stages.
it also has broad implications for targeted therapy for other diseases such as cancer and neurological disorders,"said Chien.
a make-or-break figure for those who are struggling with stunted production and less or no profit due to the disease. uring the past 15 years,
The disease starves the tree of nutrients, damages its roots and the tree produces fruits that are green and misshapen,
and the disease has affected already millions of citrus trees in North america. It has recently been found twice in California.
and fatigue has been a deadly disease for metals, "the researchers wrote.""We weaken the constraint of the substrate by making the interface between the Au (gold) nanomesh and PDMS slippery,
may aid efforts to build point-of-care devices for quick medical diagnosis of various diseases ranging from cancer, allergies, autoimmune diseases, sexually transmitted diseases (STDS),
when atoms are brought too close together-to detect a wide array of protein markers that are linked to various diseases.
allowing us to build inexpensive devices that could detect dozens of disease markers in less than five minutes in the doctor's office
and immediately start the battle against disease. Groundbreaking approach to create nanomaterials The research group lead by Professor Mauri Kostiainen works extensively with DNA NANOSTRUCTURES,
this makes our platform adaptable for many different diseases"."""Our modular platform provides significant advantages over existing methods for the detection of antibodies,"added Prof.
The finding points towards developing a powerful malaria vaccine in the hope of eradicating this debilitating and often fatal disease.
and several hundred million suffer from this disease across the globe. To add to the disease burden
the malaria parasite is increasingly becoming resistant to commonly used antimalarial drugs. Development of an antimalarial vaccine is an integral part of an effort to counter the socioeconomic burden of malaria.
passive health and behavioral monitoring paradigm to foster healthy lifestyles or identify early symptoms of certain diseases.
and systems to enable healthy living through health monitoring and disease diagnosis, management and prevention.
Certain diseases, such as lung cancer, can cause patients to give off particular smells; dogs have been known to detect these,
While treating diseases using this system is likely many years away, it could be used much sooner as a research tool,
#Liquid crystals Detect Protein Fibers Associated with Development of Neurodegenerative Diseases Liquid crystals are familiar to most of us as the somewhat humdrum stuff used to make computer displays and TVS.
as detectors for the protein fibers implicated in the development of neurodegenerative diseases such as Alzheimer's.
"Amyloid fibrils are protein aggregates that are associated with the development of neurodegenerative diseases including Huntington's disease, Parkinson's, Alzheimer's,
whether it would remove other disease-causing microorganisms.""I would want to see results for protozoa and viruses,
whether it would remove other disease-causing microorganisms.""I would want to see results for protozoa and viruses,
Pimentel will also present the research on Sunday, May 17th, at Digestive Disease Week 2015 in Washington,
comparing IBS patients to those diagnosed with inflammatory bowel disease, celiac disease and those with no GI disease.
or another that the disease was psychological, all in their head,"said Pimentel.""The fact that we can now confirm the disease through their blood,
not their head, is going to end a lot of the emotional suffering I have seen these patients endure."
developed by Pimentel to detect both anti-Cdtb and anti-vinculin antibodies in the diagnosis of irritable bowel syndrome and inflammatory bowel disease.
and suffer from life-threatening diseases such as sickle cell anaemia and thalassaemia, which require lifelong treatment with blood transfusions and medication.
#Early warning gene signature for Alzheimer's A'gene signature'that could be used to predict the onset of diseases, such as Alzheimer's,
Such a molecular profile could be useful for distinguishing people at earlier risk of age-related diseases.
This could improve upon the use of chronological age and complement traditional indicators of disease, such as blood pressure.
'The signature was found to be a reliable predictor for risk of age-related disease when studying RNA from tissues including human muscle, brain and skin.
and therefore a lower healthy age gene score, suggesting significant association with the disease. Timmons added:"
The method opens up unexpected possibilities for understanding diseases and drug mechanisms. The study's findings are reported in the September 7 issue of Nature Methods.
"This new functionality will improve our ability to decipher the complex relationships between interdependent genes responsible for many diseases,
--and such chromosome fusions can lead to diseases such as cancer. To learn more about the process, Kapoor,
Inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis, are disorders of unknown etiology that are characterized often by abdominal pain, diarrhea, bloody stool, fever,
who qualify for the special Government-led medical assistance system for intractable diseases. Currently the administration of anti-inflammatory agents only provides palliative results,
Here, they showed that SAP-1 ablation in a mouse model of inflammatory bowel disease resulted in a marked increase in the incidence and severity of bowel inflammation
and CEACAM20 to overcome intractable inflammatory bowel diseases. Prof. MATOZAKI stated, "Since the discovery of SAP-1 at Kobe University in 1994,
Our future research interests are centered on the development of new therapeutics for inflammatory bowel disease that take advantage of our understanding of SAP-1 and CEACAM20 functions
this makes our platform adaptable for many different diseases"."""Our modular platform provides significant advantages over existing methods for the detection of antibodies,"added Prof.
and blood samples have emerged as one possible way of gathering crucial information about a patient's disease.'
#Breakthrough in rare disease that causes growth of second skeleton Scientists have developed a potential antibody treatment for the rare genetic disease fibrodysplasia ossificans progressiva (FOP), in
The disease is known to be caused by mutations in the ACVR1 gene, which codes for a receptor protein that controls bone
and sometimes fatal, illness when they are infected with the influenza virus. Professor Paul Kellam of the Wellcome Trust Sanger Institute near Cambridge said:'
when exposed to a virus that is otherwise causing mild or no disease in the wider population.'
Early signs are that drugs that increase the activity of IFIT3 may be effective treatments for other viral diseases as well.'
"By understanding more about the fundamental mechanisms of the diseases, Professor Lu preselected molecules most likely to be effective as anticancer agents.
#Researchers Find New Target for Anti-Malaria Drugs A new target for drug development in the fight against the deadly disease malaria has been discovered by researchers at MIT.
This makes it more difficult for the parasite to release proteins involved in the transformation of the host cell beyond the membrane in order to spread the disease
they could be used as a drug target against the diseases they cause, including malaria, he said. his very strongly suggests that you could find small-molecule drugs to target these pores,
The findings could have implications for the prevention of neurodegenerative diseases that are characterized by plaque buildup.
or cause brain diseases. o why is the glymphatic system more effective when sleeping in the lateral position?
and therefore overall waste clearance is diminished. his could have implications for prevention of certain neurodegenerative diseases. e speculate that
or postpone onset of neurodegenerative diseases such as Alzheimer, Benveniste told Bioscience Technology. Imaging testing in humans is needed still.
and to prevent neurodegenerative diseases
#Capturing Cell Growth in 3d Replicating how cancer and other cells interact in the body is somewhat difficult in the lab. Biologists generally culture one cell type in plastic plates,
and the drugs used to treat the disease. In the Proceedings of the National Academy of Sciences, Associate professor of Chemistry Brian Miller and postdoctoral researcher Carl Whittington report that a key enzyme involved in the body response to glucose can essentially be corrupted by a new mechanism that scientists
This discovery shifts the current understanding of how this enzyme participates in certain diseases, including hyperinsulinemia and diabetes. n principle,
our findings could open the door for a new approach to treat diseases of glucose homeostasis, such as diabetes,
Miller and Whittington research showed there is actually another avenue for activation. glucokinase The work showed that this new activation mechanism is operational in clinically characterized disease forms of the enzyme.
a disease characterized by over secretion of insulin even in the absence of glucose, often leading to insulin resistance. lucokinase-associated hyperinsulinemia varies in severity depending upon the level of activation of the enzyme,
because it sheds new light onto how the functional properties of the enzyme can manifest in disease.
and disease-variant forms of glucokinase. e can see which parts of the enzyme move at what rate and speed,
As a result, some companies have started looking at other options to treat the disease, and the new findings might aid this process.
#Degenerating Neurons Respond to Gene therapy Treatment for Alzheimer Disease Degenerating neurons in patients with Alzheimer disease (AD) measurably responded to an experimental gene therapy in
The participants lived one to 10 years after treatment. ll of the Alzheimer disease brains showed anatomical evidence of a growth response to the growth factor,
We identified novel factors that might be used in reprogramming cells into so-called pluripotent stem cells for possible treatment of a range of diseases,
which the Centers for Disease Control and Prevention said accounts for over 10,000 deaths annually, mostly among hospital patients.
disrupting its disease-promoting effects. The new work led by Rice chemist Zachary Ball, Baylor pediatrician Michele Redell and MD Anderson oncologist David Tweardy appears this week in the journal Angewandte Chemie.
Such knowledge could pave the way for new drugs for a myriad of diseases, including cancer.
and structure of phosphoproteins and identify which ones are involved in disease. his innovation will help advance the understanding of human biochemistry and physiology,
Trouble in the phosphorylation process can be a hallmark of disease, such as cancer, inflammation and Alzheimer disease.
and their role in disease a daunting task. ur technology begins to make this a tractable problem,
Kinases are implicated in many diseases and therefore, of particular interest. he ability to produce kinases for study should be useful in learning how these proteins function and in developing new types of drugs,
impacting normal growth as well as cancer and disease. Dysregulation of histone methylation patterns is observed in a variety of human cancers, inflammation,
and neurodegenerative diseases, validating histone methyltransferases (HMTS) as an important class of drug targets among biomedical researchers.
and parts of Africa are counterfeit, according to The Centers for Disease Control and Prevention (CDC).
The new device uses microfluidics technology and could significantly reduce the cost of sophisticated tests for diseases such as HIV, Lyme disease and syphilis, according to the study authors.
The ability to analyze miniscule amounts of fluid could also promote more research on autoimmune joint diseases,
#chillesheelof Sickle cell Disease? Researchers from Dana-Farber/Boston Children Cancer and Blood disorders Center have found that changes to a small stretch of DNA may circumvent the genetic defect behind sickle cell disease.
The discovery, outlined in the journal Nature, opens a promising path for developing gene-editing approaches to treat the disease and other hemoglobin disorders.
This stretch of DNA, called an enhancer, controls a molecular switch that determines whether a red blood cell produces the adult form of hemoglobin
which in sickle cell disease is mutated or a fetal form that is unaffected by and counteracts the effects of the mutation.
Other studies have indicated that sickle-cell patients with elevated levels of fetal hemoglobin have a milder form of the disease.
when the journal Science published their report of the discovery of the enhancer that directs expression of BCL11A only in red blood cells. ee now targeted the modifier of the modifier of a disease-causing gene,
and associate chief of hematology/oncology at Boston Children Hospital. t a very different approach to treating disease. he data provide proof of principle that targeted edits to BCL11A enhancer in blood stem cells could be an attractive approach
for curing sickle cell disease and related conditions. hese experiments may have revealed the genetic Achillesheel of sickle cell disease,
said Orkin. lterations to these specific portions of the enhancer have the same effect as knocking the whole enhancer out altogether,
to combat disease, for filtering fresh drinking water, and much more. Now, researchers from MIT and the Federal University of Goias in Brazil have developed a new technique that uses ultraviolet (UV LIGHT to extract man-made pollutants from soil and water.
Drug delivery and beyond The power of nanoparticles is also being harnessed to fight life-threatening lung diseases, such as cystic fibrosis.
And studying this interface is critical in certain diseases she added. n Krabbe, for example, the problem is not just that there isn sufficient myelin,
The discovery will help improve the understanding of and development of new treatments for myelin diseases.
Feltri explained. t provides a glimpse into the social life of cells. his work has important implications for diseases of myelin such as Krabbe disease,
and other neurodegenerative diseases, because the communication between glial cells and neurons is vital for neuroprotection,
extending far away from the glial cell. his has profound implications for glial disease like Krabbe, Charcot-Marie Tooth, peripheral neuropathies or Multiple sclerosis,
said Poitelon. imilarly, neurodegenerative diseases like Huntington disease or Lou Gehrig's, that were considered uniquely diseases of neurons in the past,
are considered now diseases of cellular communications between neurons and glial cells. The work was funded by the National institutes of health o
#Down syndrome Research Untangles Therapeutic Possibilities for Alzheimer More than five million Americans are living with Alzheimer disease (AD.
Of them, 400,000 also have Down syndrome. Both groups have similar looking brains with higher levels of the protein beta amyloid.
and Down syndrome. eople with Down syndrome represent the world largest population of predetermined Alzheimer disease. By studying these individuals,
we can develop insights into how Alzheimer disease naturally progresses and potential drug targets, said principal investigator Michael Rafii, M d.,Ph d.,assistant professor of neurosciences and interim co-director of the Alzheimer Disease Cooperative Study (ADCS) at UC San diego. The 3-year study
, called The down Syndrome Biomarker Initiative (DSBI), involved twelve participants between the ages of 30 and 60 with Down syndrome,
and retinal amyloid imaging. his study shows some of the earliest known Alzheimer disease biomarker changes in adults with Down syndrome
and underscores the need for additional studies, said Rafii. his study will set the stage for the first clinical trial of anti-beta amyloid therapy in the preclinical treatment of Alzheimer disease in adults with Down syndrome.
which includes the Shiley-Marcos Alzheimer Disease Research center, under the direction of Douglas Galasko, M d,
While treating diseases using this system is likely many years away, it could be used much sooner as a research tool,
a finding that may have ramifications for preventing stroke and the early diagnoses of Alzheimer disease.
such as hypertension and diabetes, Wang said. rowing evidence suggests intracranial vascular pathology also may be associated with the origin and progression of cerebrovascular disorders and neurodegenerative diseases, such as Alzheimer disease,
the aorta. e hope our technique can provide an early marker for a number of socioeconomically important diseases like Alzheimer,
The development of early bio-or imaging markers for Alzheimer is of great importance for slowing disease progression.
The need for a new approach to treatment of Alzheimer disease is urgent. Alzheimer is the most common age-related dementia
development and disease The discovery of human orgsself-renewing niche and remarkable generative capacity reinforces the idea that these cells may have been responsible for the expansion of the cerebral cortex in our primate ancestors,
which are thought to affect cell types not found in the mouse models that are used often to study such diseases.
or in diseases of the cerebral cortex, this is a really exciting discovery. The study represents the first salvo of a larger BRAIN INITIATIVE-funded project in Kriegstein lab to understand the thousands of different cell types that occupy the developing human brain t the moment
#Gene Test Finds Which Breast cancer Patients Can Skip Chemo Many women with early-stage breast cancer can skip chemotherapy without hurting their odds of beating the disease-good news from a major study that shows
as has been proposed to treat Parkinson disease. Boutin was interested in building working 3-D cell cultures to study how adult neural stem cells develop.
This was used then to study anonymous tumor samples taken from patients with colorectal cancer, a common form of the disease.
which plays a role in neurodegenerative diseases, were lower in neurons derived from older patients.
Children with the disease lose significant muscle strength early in life. The discovery stems from the persistence of a father--Scott Frewing
and his search for and partnership with the genetic scientist--Dr. Elizabeth Mcnally--who studies the disease.
The rare form of the disease is Limb Girdle Muscular dystrophy Type 2c. Mcnally is director of the Center for Genetic Medicine at Northwestern University Feinberg School of medicine and the former director of the Institute of Cardiovascular Research at UCHICAGO,
another form of muscle disease, exon skipping coaxes cells to kipover abnormal sections of the genetic code,
which included Quan Gao a University of Chicago graduate student and Dr. Eugene Wyatt, a postdoctoral fellow at Northwestern, demonstrated that protein made from exon skipping was functional to stabilize and slow progress of the disease.
Working with human cells obtained from individuals with the disease the team showed that exon skipping can be induced successfully with antisense compounds. e recognize that this is version 1. 0,
if this can stabilize individuals with this disease, even if it gave them 10 more years of walking, that huge.
The disease is an inherited disorder that is found in patients around the world and is prevalent in France, northern Africa and parts of South america.
Although children with the disease are able to live normally at young ages, over time their deteriorating muscles prevent them from engaging in a number of typical childhood activities.
Many of the children with the disease are in a wheelchair in their mid-to-late teenage years.
Kurt and Peter, were diagnosed with the disease in 2009 and 2010 respectively. The boysfamily and friends started the Kurt+Peter Foundation in 2010 to apply promising research to Limb Girdle Muscular dystrophy Type 2c.
she was one of the only researchers worldwide working on the disease. Frewing had heard of exon skipping
Mcnally didn think that exon skipping would make the tiny relevant protein in the disease functional.
and development of this potential therapy. here are always new ways to treat a disease,
Mcnally said. his partnership is a perfect example of how precision medicine can help address very rare diseases.
"This is a terrible disease affecting children worldwide, and we hope to soon be able to provide families with treatment techniques that can lessen the disease severity.
The agreement among the Kurt+Peter Foundation, UCHICAGO and Northwestern is the first license UCHICAGO has executed with a foundation. his arrangement is a great example of how research institutions
a life-threatening disease characterized by the inflammation and hardening of skin tissue. The new study is the first to investigate the role of this molecule in skin fibrosis
and paves the way toward new and improved therapies for the disease. The study reveals a new mechanism for the development of fibrosis in skin tissues
The disease can affect various tissues including those of the skin, lungs, heart and liver.
and there are no proven cures or treatments for the disease. In this study, researchers discovered that a molecule called fibulin-5 played a role in the development of skin fibrosis in mice.
until now. linical trials to test the effectiveness of potential therapies for many known fibrotic diseases have so far been disappointing.
Our study points to a new way to target this debilitating disease, said Jamora. By focusing on elastin, the team discovered that the development of fibrosis in skin tissues was linked to a particular molecule:
we are looking to provide hope for a disease condition that contributes to approximately 30 percent of all deaths worldwide,
and to RNA in the brain cells of people with other diseases. They found that GDF10 regulates a unique collection of molecules that improves recovery after stroke.
Stroke kills nearly 130,000 Americans each year one of every 20 deaths in the U s. according to the Centers for Disease Control.
Treating just one severe case of the disease can cost regulators more than $4. 5 million
50.0 percent and 47.8 percent, respectively) in people with advanced ALK-positive non-small cell lung cancer (NSCLC) whose disease had progressed following treatment with crizotinib.
and these studies suggest that alectinib can shrink tumors in people with this difficult-to-treat disease,
whose disease progressed on crizotinib. Breakthrough Therapy Designation is designed to expedite the development and review of medicines intended to treat serious diseases
and to help ensure patients have access to them through FDA approval as soon as possible. ALEX, a global randomized Phase III study, is ongoing,
whose disease progressed on crizotinib. The study showed by assessment of an independent review committee an ORR in 50.0 percent of people treated with alectinib,
whose disease had spread to the brain or other parts of the CNS. In addition, the people whose tumors shrank in response to alectinib continued to respond for a median of 11.2 months (DOR
whose disease progressed on crizotinib. The study showed by assessment of an independent review committee an ORR in 47.8 percent of people treated with alectinib,
whose disease had spread to the brain or other parts of the CNS. In addition the people whose tumors shrank in response to alectinib continued to respond for a median of 7. 5 months (DOR, immature data.
when the disease is advanced in the stages. About Genentech in Lung cancer Lung cancer is a major area of focus and investment for Genentech,
medicines and tests that can help people with this deadly disease. Our goal is to provide an effective treatment option for every person diagnosed with lung cancer.
or to boost the immune system to combat the disease. About Genentech Founded more than 35 years ago
Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011